Literature DB >> 22440044

Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.

Sang Soo Kim1, Sang Heon Song, In Joo Kim, Ji Young Yang, Jeong Gyu Lee, Ihm Soo Kwak, Yong Ki Kim.   

Abstract

AIM: The aim of this study was to evaluate the association of urinary tubular markers, interleukin-18 (IL-18) and angiotensinogen with albuminuria in early nephropathy of type 2 diabetics.
METHODS: Urine levels of tubular markers (kidney injury molecule [KIM]-1, neutrophil gelatinase-associated lipocalin [NGAL] and liver-type fatty acid-binding protein [L-FABP]), proinflammatory marker (IL-18), and a marker of intrarenal renin-angiotensin system (RAS) status (angiotensinogen) were determined in 118 patients with type 2 diabetes mellitus and 25 non-diabetic controls with estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m(2).
RESULTS: Urinary levels of KIM-1, NGAL, IL-18 and angiotensinogen were significantly higher in macroalbuminuria group compared with control and normo- and microalbuminuria groups but not significantly different between control and normoalbuminuria group. Urinary tubular markers were positively correlated with urinary IL-18 and angiotensinogen, respectively. The urinary albuminuria was correlated with all investigated urinary markers in univariate analysis. After adjusting for several clinical parameters, urinary KIM-1, NGAL and angiotensinogen were significantly associated with albuminuria.
CONCLUSIONS: The results of this study suggest that urinary tubular markers may be independently associated with albuminuria in the early stage of nephropathy in type 2 diabetics (eGFR ≥ 60 mL/min/1.73 m(2)) and may reflect inflammatory processing and the activation of the intrarenal RAS.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440044     DOI: 10.1016/j.diabres.2012.02.019

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  42 in total

1.  Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.

Authors:  Gudeta D Fufaa; E Jennifer Weil; Robert G Nelson; Robert L Hanson; Joseph V Bonventre; Venkata Sabbisetti; Sushrut S Waikar; Theodore E Mifflin; Xiaoming Zhang; Dawei Xie; Chi-Yuan Hsu; Harold I Feldman; Josef Coresh; Ramachandran S Vasan; Paul L Kimmel; Kathleen D Liu
Journal:  Diabetologia       Date:  2014-10-15       Impact factor: 10.122

2.  Association between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients.

Authors:  Huan Wang; Kai Cui; Ke Xu; Shixin Xu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

Authors:  Jan Wysocki; Anne Goodling; Mar Burgaya; Kathryn Whitlock; John Ruzinski; Daniel Batlle; Maryam Afkarian
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-03

Review 4.  Role of stimulated intrarenal angiotensinogen in hypertension.

Authors:  Ryousuke Satou; Weijian Shao; L Gabriel Navar
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-05-18

5.  Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus.

Authors:  Sang Soo Kim; Sang Heon Song; Jong Ho Kim; Yun Kyung Jeon; Bo Hyun Kim; Min-Cheol Kang; Sung Wan Chun; Soo Hyun Hong; Michelle Chung; Yong Ki Kim; In Joo Kim; Young-Bum Kim
Journal:  Clin Endocrinol (Oxf)       Date:  2017-05-22       Impact factor: 3.478

Review 6.  Discovering the route from inflammation to pancreatic cancer.

Authors:  N Momi; S Kaur; S R Krishn; S K Batra
Journal:  Minerva Gastroenterol Dietol       Date:  2012-12

7.  Do serum and urinary concentrations of kidney injury molecule-1 in healthy newborns depend on birth weight, gestational age or gender?

Authors:  M Kamianowska; M Szczepański; E E Kulikowska; B Bebko; A Wasilewska
Journal:  J Perinatol       Date:  2016-09-29       Impact factor: 2.521

8.  Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.

Authors:  Maryam Afkarian; Leila R Zelnick; John Ruzinski; Bryan Kestenbaum; Jonathan Himmelfarb; Ian H de Boer; Rajnish Mehrotra
Journal:  J Diabetes Complications       Date:  2015-09-02       Impact factor: 2.852

9.  The ZDSD rat: a novel model of diabetic nephropathy.

Authors:  Richard G Peterson; Charles Van Jackson; Karen M Zimmerman
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

Review 10.  Role of the intrarenal renin-angiotensin system in the progression of renal disease.

Authors:  Maki Urushihara; Shoji Kagami
Journal:  Pediatr Nephrol       Date:  2016-07-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.